# A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

> **NCT05095727** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **ModernaTX, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Glycogen Storage Disease

## Interventions

- **DRUG:** mRNA-3745

## Key facts

- **NCT ID:** NCT05095727
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05095727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05095727, "A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05095727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*